Title : Pharmacokinetics of quinacrine in the treatment of prion disease.

Pub. Date : 2004 Nov 29

PMID : 15569390






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In a cell-based assay, quinacrine inhibits the conversion of normal host prion protein (PrPC) to PrPSc at a half-maximal concentration of 300 nM. Quinacrine prion protein Mus musculus
2 If quinacrine penetrates brain tissue in concentrations exceeding that demonstrated for in vitro inhibition of PrPSc, it may be useful in the treatment of prion disease. Quinacrine prion protein Mus musculus
3 RESULTS: Quinacrine was demonstrated to penetrate rapidly into brain tissue, achieving concentrations up to 1500 ng/g, which is several-fold greater than that demonstrated to inhibit formation of PrPSc in cell culture. Quinacrine prion protein Mus musculus
4 The relative importance of free quinacrine in these compartments upon the conversion of normal host prion protein (PrPC) to PrPSc will be critical toward its potential benefit. Quinacrine prion protein Mus musculus